References
- Bassand J. P., Hamm C. W., Ardissino D., Boersma E., Budaj A., Fernandez‐Aviles F., Fox K. A., et al. Guidelines for the diagnosis and treatment of non‐ST‐segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598–660
- Schwartz R. S., Bayes‐Genis A., Lesser J. R., Sangiorgi M., Henry T. D., Conover C. A. Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers. J Interv Cardiol 2003; 16: 231–42
- Bayes‐Genis A., Conover C. A., Overgaard M. T., Bailey K. R., Christiansen M., Holmes D. R., Jr, et al. Pregnancy‐associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022–9
- Bayes‐Genis A., Schwartz R. S., Lewis D. A., Overgaard M. T., Christiansen M., Oxvig C., et al. Insulin‐like growth factor binding protein‐4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 335–41
- Lund J., Qin Q. P., Ilva T., Pettersson K., Voipio‐Pulkki L. M., Porela P., et al. Circulating pregnancy‐associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003; 108: 1924–6
- Cosin‐Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M. T., Cole D., et al. Pregnancy‐associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004; 109: 1724–8
- Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Simoons M. L., Zeiher A. M. Pregnancy‐associated plasma protein‐A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005; 45: 229–37
- Rossen M., Iversen K., Teisner A., Teisner B., Kliem A., Grudzinskas G. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy‐associated plasma protein (PAPP‐A) in acute coronary syndrome. Clin Biochem 2007; 40: 478–84
- Westergaard J. Studies on pregnancy associated plasma protein A (PAPP‐A) in normal and abnormal pregnancy., [Thesis/Dissertion]
- Libby P., Ridker P. M., Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–43
- Laursen L. S., Overgaard M. T., Nielsen C. G., Boldt H. B., Hopmann K. H., Conover C. A., et al. Substrate specificity of the metalloproteinase pregnancy‐associated plasma protein‐A (PAPP‐A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem J 2002; 367: 31–40
- Conover C. A., Harrington S. C., Bale L. K., Oxvig C. Surface association of pregnancy‐associated plasma protein‐A accounts for its colocalization with activated macrophages. Am J Physiol Heart Circ Physiol 2007; 292: 994–1000
- Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481–8
- Lund J., Qin Q. P., Ilva T., Nikus K., Eskola M., Porela P., et al. Pregnancy‐associated plasma protein A: a biomarker in acute ST‐elevation myocardial infarction (STEMI). Ann Med 2006; 38: 221–8
- Brugger‐Andersen T., Hetland O., Ponitz V., Grundt H., Nilsen D. W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy‐associated plasma protein A, soluble fibrin and D‐dimer in acute myocardial infarction. Thromb Res 2007; 119: 415–21
- Andersen D. C., Koch C., Jensen C. H., Skjodt K., Brandt J., Teisner B. High prevalence of human anti‐bovine IgG antibodies as the major cause of false positive reactions in two‐site immunoassays based on monoclonal antibodies. J Immunoassay Immunochem 2004; 25: 17–30